4D pharma plc Operating Cash Flow
4D pharma plc reported Operating Cash Flow of -$37.92 million for the 12-month period ending 2021-12-31, per its 20-F filed 2022-03-31.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2022-03-31
| Period end | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|
| 2021-12-31 | -$37.92M 20-F · filed 2022-03-31 | |
| 2021-06-30 | -$20.43M 6-K/A · filed 2022-02-18 | |
| 2020-12-31 | -$27.27M 20-F · filed 2022-03-31 | |
| 2020-06-30 | -$17.60M 6-K/A · filed 2022-02-18 | |
| 2019-12-31 | -$28.68M 20-F · filed 2022-03-31 | |
| 2018-12-31 | -$30.16M 20-F/A · filed 2021-04-30 |